Anke Bio-precision medical technology breakthrough: cancer treatment is expected to succeed

Can precision medicine cure "cancer"? The breakthrough in clinical treatment allowed Anke Bio to give a definite answer. With the gradual clarification of national policies, the industrialization horn of precision treatment of tumors such as domestic CAR-T (cell-specific immunotherapy) has also been blown.

On December 19, Anke Biotechnology executives said in an interview with reporters that cancer treatment has entered the era of precision medicine . With the advancement of technologies such as CAR-T, it is confident that cancer will become a chronic disease, enabling patients to “ Survival with tumors to improve the quality of life of patients. At the same time, the company has built a CAR-T production line in accordance with the GMP certification standards for pharmaceuticals, and will strive to become the first batch of enterprises to declare CAR-CD19 in China.

Due to the huge commercial prospects and practical significance, the concept of tumor precision treatment has once stood in the A-share market “window” in the past two years. Among them, CAR-T has attracted much attention because of the title of “the ultimate weapon for human beings to overcome cancer”. But like many new things, the controversy about "precise treatment of tumors is only a hypothesis to be proved" is endless.

安科生物获技术突破 精准医疗治癌有望成真

Clinical breakthrough

Prove that cancer is curable

Dare to say that "the cure of cancer is not a dream", Anke bio-derived gas comes from the company's breakthrough in clinical treatment. In November this year, a late-stage relapsed patient diagnosed with acute lymphoblastic leukemia in Anhui Provincial Hospital was treated with CAR-T for about 10 days, and no cancer cells were detected in the body. In December, a relapsed patient with diffuse large B-cell lymphoma also achieved complete remission because of the CAR-T treatment provided by Anke Bio.

In a very simplified way, the basic principle of CAR-T treatment is to isolate immune T cells from cancer patients and genetically engineer T cells with chimeric antigen receptors (CAR) that recognize and kill tumor cells. Then, a large number of augmented CAR-T cells are returned to the patient, and the immune cells are subjected to a "sweeping attack" on the tumor cells to achieve the effect of clearing the tumor cells and alleviating cancer.

Auxiliary Facilities

The greenhouse a filled with equipment like hydroponic, irrigation, auxiliary lighting ,temperature and humidity control and also may be automatically controlled by a computer to maximize potential growth.
Hydroponics can be used to make the most use of the interior space. The relatively closed environment of a greenhouse has its own unique management requirements, compared with outdoor production. Pests and diseases, and extremes of heat and humidity, have to be controlled, and irrigation is necessary to provide water. Most greenhouses use sprinklers or drip lines. Significant inputs of heat and light may be required, particularly with winter production of warm-weather vegetables.

Auxiliary Facilities,Greenhouse Ventilation Fan,Greenhouse Fogging System,Greenhouse Movable Irrigation

JIANGSU SKYPLAN GREENHOUSE TECHNOLOGY CO.,LTD , https://www.alibabagreenhouse.com